Identification of Distinct Genetic Profiles of Palindromic Rheumatism Using Whole-Exome Sequencing.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
11 2023
Historique:
revised: 04 05 2023
received: 06 03 2022
accepted: 11 05 2023
medline: 31 10 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: ppublish

Résumé

Previous studies have underlined the genetic susceptibility in the pathogenesis of palindromic rheumatism (PR), but the known PR loci only partially explain the disease's genetic background. We aimed to genetically identify PR by whole-exome sequencing (WES). This multicenter prospective study was conducted in 10 Chinese specialized rheumatology centers between September 2015 and January 2020. WES was performed in 185 patients with PR and in 272 healthy controls. PR patients were divided into PR subgroups who were negative for anti-citrullinated protein antibody (ACPA-) and positive for ACPA (ACPA+) according to ACPA titer (cutoff value 20 IU/liter). We conducted whole-exome association analysis for the WES data. We used HLA imputation to type HLA genes. In addition, we used the polygenic risk score to measure the genetic correlations between PR and rheumatoid arthritis (RA) and the genetic correlations between ACPA- PR and ACPA+ PR. Among 185 patients with PR enrolled in our study, 50 patients (27.02%) were ACPA+ and 135 PR patients (72.98%) were ACPA-. We identified 8 novel loci (in the ACPA- PR group: ZNF503, RPS6KL1, HOMER3, HLA-DRA; in the ACPA+ PR group: RPS6KL1, TNPO2, WASH2P, FANK1) and 3 HLA alleles (in the ACPA- PR group: HLA-DRB1*0803 and HLA-DQB1; in the ACPA+ PR group: HLA-DPA1*0401) that were associated with PR and that surpassed genome-wide significance (P < 5 × 10 This study demonstrated the distinct genetic background between ACPA- and ACPA+ PR patients. Additionally, our findings strengthened that PR and RA were not genetically similar.

Identifiants

pubmed: 37219934
doi: 10.1002/art.42614
doi:

Substances chimiques

Autoantibodies 0
Peptides, Cyclic 0
HLA-DRB1 Chains 0

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1947-1957

Informations de copyright

© 2023 American College of Rheumatology.

Références

Guerne PA, Weisman MH. Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med 1992;93:451-60.
Mankia K, Emery P. What can palindromic rheumatism tell us? Best Pract Res Clin Rheumatol 2017;31:90-8.
Ahn JK, Hwang J, Seo GH. Incidence and risk of developing rheumatic diseases in 19,724 patients with palindromic rheumatism in South Korea: a nationwide population-based study. Joint Bone Spine 2021;88:105128.
Russell AS, Devani A, Maksymowych WP. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J Rheumatol 2006;33:1240-2.
Cañete JD, Arostegui JI, Queiró R, et al. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum 2007;56:2784-8.
Maksymowych WP, Suarez-Almazor ME, Buenviaje H, et al. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J Rheumatol 2002;29:2319-26.
Pasero G, Barbieri P. Palindromic rheumatism: you just have to think about it! Clin Exp Rheumatol 1986;4:197-9.
Koskinen E, Hannonen P, Sokka T. Palindromic rheumatism: longterm outcomes of 60 patients diagnosed in 1967-84. J Rheumatol 2009;36:1873-5.
Kim SK, Lee HS, Lee KW, et al. Palindromic rheumatism: different genetic background implies a distinct disease entity. Ann Rheum Dis 2006;65:1539-40.
Wang J, Zhang Q, Xu L, et al. A case of episodic and refractory arthritis due to a novel variant of NLRP12. Ann Rheum Dis 2022;81:e33.
Lu LY, Keng HM, Chu JJ, et al. TNF receptor I polymorphism is associated with persistent palindromic rheumatism. Scand J Rheumatol 2007;36:278-84.
Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, et al. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol 1999;26:540-5.
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-60.
Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078-9.
McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
Danecek P, Auton A, Abecasis G, et al. The variant call format and VCFtools. Bioinformatics 2011;27:2156-8.
Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010;26:2336-7.
Cook S, Choi W, Lim H, et al. Accurate imputation of human leukocyte antigens with CookHLA. Nat Commun 2021;12:1264.
Choi W, Luo Y, Raychaudhuri S, et al. HATK: HLA analysis toolkit. Bioinformatics 2021;37:416-8.
Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506:376-81.
Euesden J, Lewis CM, O'Reilly PF. PRSice: polygenic risk score software. Bioinformatics 2015;31:1466-8.
Choi SW, Mak TS, O'Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc 2020;15:2759-72.
Ravasio V, Ritelli M, Legati A, et al. GARFIELD-NGS: Genomic vARiants FIltering by dEep Learning moDels in NGS. Bioinformatics 2018;34:3038-40.
Kobayashi I, Yamazaki Y, Tozawa Y, et al. Progression of palindromic rheumatism to juvenile idiopathic arthritis in a Japanese girl carrying heterozygous L110P-E148Q substitutions of MEFV gene. Mod Rheumatol 2018;28:365-8.
Suganuma Y, Tanaka H, Kawase A, et al. Expression of a PYCARD/ASC variant lacking exon 2 in Japanese patients with palindromic rheumatism increases interleukin-1β secretion. Asian Pac J Allergy Immunol 2022;40:81-6.
Wang J, Zhang Q, Xu L, et al. A case of episodic and refractory arthritis due to a novel variant of NLRP12. Ann Rheum Dis 2022;81:e33.
Costantini A, Skarp S, Kampe A, et al. Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility. Front Endocrinol (Lausanne) 2018;9:380.
Abdulkadir SA, Krishna S, Thanos D, et al. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J Exp Med 1995;182:487-500.
Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
Huang GN, Huso DL, Bouyain S, et al. NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins. Science 2008;319:476-81.
Son A, Kang N, Oh SY, et al. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism. J Endocrinol 2019;242:241-9.
Guttinger S, Muhlhausser P, Koller-Eichhorn R, et al. Transportin2 functions as importin and mediates nuclear import of HuR. Proc Natl Acad Sci U S A 2004;101:2918-23.
Beauchamp P, Nassif C, Hillock S, et al. The cleavage of HuR interferes with its transportin-2-mediated nuclear import and promotes muscle fiber formation. Cell Death Differ 2010;17:1588-99.
Yin G, Liu Z, Wang Y, et al. ZNF503 accelerates aggressiveness of hepatocellular carcinoma cells by down-regulation of GATA3 expression and regulated by microRNA-495. Am J Transl Res 2019;11:3426-37.
Chereau D, Kerff F, Graceffa P, et al. Actin-bound structures of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly. Proc Natl Acad Sci U S A 2005;102:16644-9.
Orange JS, Roy-Ghanta S, Mace EM, et al. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest 2011;121:1535-48.
Wang H, Song W, Hu T, et al. Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway. Cell Mol Life Sci 2011;68:2129-39.
Mankia K, D'Agostino MA, Wakefield RJ, et al. Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Ann Rheum Dis 2019;78:43-50.
Grotzinger AD, Rhemtulla M, de Vlaming R, et al. Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nat Hum Behav 2019;3:513-25.
Guo J, Zhang T, Cao H, et al. Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population. Ann Rheum Dis 2019;78:773-80.

Auteurs

Chenxiang Zheng (C)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Fan Wang (F)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yue Sun (Y)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zhuochao Zhou (Z)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yijun You (Y)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Dongyi He (D)

Department of Rheumatology, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Xiaoxia Zhu (X)

Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.

Lindi Jiang (L)

Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.

Cui Lu (C)

Department of Haematology and Rheumatology, Shanghai Songjiang District Central Hospital, Shanghai, PR China.

Lijun Wu (L)

Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.

Hongzhi Wang (H)

Department of Rheumatology, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, Zhejiang, China.

Hanying Mei (H)

Department of Rheumatology and Immunology, Affiliated Jiujiang Hospital of Nanchang University, Jiujiang, Jiangxi, China.

Ting Zeng (T)

Rheumatology Department, Xinhua Hospital Chongming Branch, Shanghai, China.

Hui Zheng (H)

The Second Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.

Jialing Teng (J)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Honglei Liu (H)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Xiaobing Cheng (X)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yutong Su (Y)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Hui Shi (H)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Qiongyi Hu (Q)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Xueming Jian (X)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Aamir Fahira (A)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Qiangzhen Yang (Q)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Ke Wang (K)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Yanqin Wen (Y)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Zhuo Wang (Z)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.

Jinyan Huang (J)

Biomedical Big Data Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Chengde Yang (C)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yongyong Shi (Y)

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, and Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China.

Junna Ye (J)

Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH